ClinicalTrials.Veeva

Menu
H

Hamzavi Dermatology | Canton

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

JNJ-77242113
TNX-102
Estradiol
Relugolix
Norethindrone Acetate

Parent organization

This site is a part of Hamzavi Dermatology

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 4 total trials

A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis (ICONIC-ADVANCE 2)

The purpose of the study is to evaluate how effective JNJ-77242113 is in participants with moderate to severe plaque psoriasis compared to placebo an...

Enrolling
Plaque Psoriasis
Drug: Deucravacitinib Matching Placebo
Drug: JNJ-77242113 Matching Placebo

Trial sponsors

M
Janssen (J&J Innovative Medicine) logo
Tonix Pharmaceuticals logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems